Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer (Jun, 10.1080/14712598.2024.2373320, 2024)

被引：0
|
作者：
Fontenot, V. E.
Francoeur, A.
Tewari, K. S.
机构：
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2024年 / 24卷 / 08期
关键词：
D O I：
10.1080/14712598.2024.2388405
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：0i / 0i
页数：1
相关论文
共 50 条
  • [41] Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review
    Muratori, Leonardo
    La Salvia, Anna
    Sperone, Paola
    Di Maio, Massimo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 139 : 41 - 52
  • [42] Real-world use of bevacizumab in metastatic colorectal, metastatic breast, advanced ovarian and cervical cancer: a systematic literature review
    Raouf, Sherif
    Bertelli, Gianfilippo
    Ograbek, Agnes
    Field, Polly
    Tran, Irwin
    FUTURE ONCOLOGY, 2019, 15 (05) : 543 - 561
  • [43] A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
    Lorusso, Domenica
    Petrelli, Fausto
    Coinu, Andrea
    Raspagliesi, Francesco
    Barni, Sandro
    GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 117 - 123
  • [44] A comprehensive bibliometric analysis (2000-2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer
    Duan, Yuanqiong
    Yang, Lin
    Wang, Wenxiang
    Zhang, Peixuan
    Fu, Kaiyu
    Li, Wen
    Yin, Rutie
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
    Oaknin, Ana
    Ghamande, Sharad A.
    Kasamatsu, Yuka
    Gil-Martin, Marta
    Grau-Bejar, Juan Francisco
    Garcia-Duran, Carmen
    Sato, Masashi
    Siddiqui, Abdul
    Chaudhary, Surendra Pal
    Vugmeyster, Yulia
    Hasegawa, Kosei
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 975 - 983
  • [46] BEAU BIDEN CANCER MOONSHOT PROGRESS REPORT ON ADVANCED CERVICAL CANCER: PILOT PROJECT ON DNA/RNA EXTRACTION FROM RECURRENT AND METASTATIC CARCINOMA SPECIMENS
    Hari, A.
    Sill, M.
    Monk, B.
    Birrer, M.
    Lankes, H.
    Filiaci, V.
    Ramirez, N.
    Wei, L.
    Tewari, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A59 - A59
  • [47] Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapies
    Togasaki, Kazuhiro
    Sukawa, Yasutaka
    Kanai, Takanori
    Takaishi, Hiromasa
    ONCOTARGETS AND THERAPY, 2018, 11 : 8239 - 8250
  • [48] Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies
    Ross, Jeffrey S.
    Gay, Laurie M.
    Wang, Kai
    Ali, Siraj M.
    Chumsri, Saranya
    Elvin, Julia A.
    Bose, Ron
    Vergilio, Jo-Anne
    Suh, James
    Yelensky, Roman
    Lipson, Doron
    Chmielecki, Juliann
    Waintraub, Stanley
    Leyland-Jones, Brian
    Miller, Vincent A.
    Stephens, Philip J.
    CANCER, 2016, 122 (17) : 2654 - 2662
  • [49] Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
    Tobias Engel Ayer Botrel
    Otávio Clark
    Rodolfo Borges dos Reis
    Antônio Carlos Lima Pompeo
    Ubirajara Ferreira
    Marcus Vinicius Sadi
    Francisco Flávio Horta Bretas
    BMC Urology, 14
  • [50] Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
    Ayer Botrel, Tobias Engel
    Clark, Otavio
    dos Reis, Rodolfo Borges
    Lima Pompeo, Antonio Carlos
    Ferreira, Ubirajara
    Sadi, Marcus Vinicius
    Horta Bretas, Francisco Flavio
    BMC UROLOGY, 2014, 14
12345